can you switch from semaglutide to tirzepatide how do Switch from Semaglutide to Tirzepatide: A Step-by-Step Guide How to Switch from Wegovy

doi: 10.1002/path.1700350305 2 FuYSKayeGILattesR

Hypoglycemia occurred in 0.5% to 0.6% of semaglutide patients and 0 to 1.1% of placebo patients in the STEP 1, STEP 3, and STEP 4 studies, while in the STEP 2 study, where patients also had type 2 diabetes, they occurred in 6% of semaglutide patients and 3% of placebo patients

While these drugs offer many benefits, they also come with significant downsides

Proper dosing and administration of Tirzepatide are crucial for individuals looking to manage obesity or weight loss successfully

Only one of the trials included in the systematic review used the next-generation GLP-1 agonist semaglutide to treat obesity in adolescents aged 1218 years, and none used the combined GLP-1 and glucose-dependent insulinotropic peptide agonist, tirzepatide